Golumbeski George 4
4 · Acumen Pharmaceuticals, Inc. · Filed Nov 10, 2025
Insider Transaction Report
Form 4
Golumbeski George
Director
Transactions
- Award
Stock Option (right to buy)
2025-11-06+50,000→ 50,000 totalExercise: $1.90Exp: 2035-11-06→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in equal monthly installments over a three-year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date and shall vest and become immediately exercisable prior to the effectiveness of a change in control.